SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-005802
Filing Date
2022-04-19
Accepted
2022-04-19 13:51:36
Documents
5
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A rkda-fy21-proxy_def14a.htm DEF 14A 1021431
2 GRAPHIC img194726254_0.jpg GRAPHIC 29171
3 GRAPHIC img194726254_1.jpg GRAPHIC 97321
4 GRAPHIC img194726254_2.jpg GRAPHIC 127900
5 GRAPHIC img194726254_3.jpg GRAPHIC 140815
  Complete submission text file 0000950170-22-005802.txt   1567253
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37383 | Film No.: 22834394
SIC: 0100 Agricultural Production-Crops